| Identification | Back Directory | [Name]
AMINOREX | [CAS]
2207-50-3 | [Synonyms]
Apiquel
McN-742
AMINOREX
NSC-66952
CPDD 0039
NSC 66592
aminoxafen
aminoxaphen
Aminorex solution
AMINOREX USP/EP/BP
Aminorex Solution, 100ppm
5-Phenyl-2-oxazolin-2-amine
2-amino-5-phenyl-2-oxazolin
2-amino-5-phenyl-2-oxazoline
AMINOREX 4,5-DIHYDRO-5-PHENYL-
4,5-dihydro-5-phenyl-2-oxazolamin
4,5-dihydro-5-phenyl-2-oxazolamine
2-Oxazolamine, 4,5-dihydro-5-phenyl-
(5-phenyl-4,5-dihydrooxazol-2-yl)amine
5-phenyl-4,5-dihydro-1,3-oxazol-2-amine
4,5-Dihydro-5-phenyl-2-oxazolamine, Aminoxaphen | [Molecular Formula]
C9H10N2O | [MDL Number]
MFCD00214070 | [MOL File]
2207-50-3.mol | [Molecular Weight]
162.19 |
| Chemical Properties | Back Directory | [Melting point ]
136-138° | [Boiling point ]
288.88°C (rough estimate) | [density ]
1.1436 (rough estimate) | [refractive index ]
1.5600 (estimate) | [Fp ]
2℃ | [storage temp. ]
-20°C | [solubility ]
0.1 M HCl: soluble | [form ]
solid | [pka]
8.19±0.70(Predicted) | [color ]
white |
| Hazard Information | Back Directory | [Uses]
Aminorex is a metabolite of Levamisole | [Uses]
It is a metabolite of Levamisole | [Definition]
ChEBI: Aminorex is a member of benzenes. | [Brand name]
Apiquel (Ortho-McNeil);Mcn 742;Menocil. | [World Health Organization (WHO)]
Aminorex, an anorexic agent, was introduced over twenty years
ago for the treatment of obesity. Between 1967 and 1971 its use was associated
with cases of pulmonary hypertension which led to its withdrawal in the Federal
Republic of Germany. WHO has no information to suggest that this drug remains
commercially available. |
|